3.8
细菌性脑膜炎通常始于病原体(如Neisseria meningitidis和Streptococcus pneumoniae)在鼻咽部定植并侵入血流。这一过程由细菌的毒力因子所促进,例如多糖荚膜能够抵抗吞噬作用和补体介导的杀伤。较少情况下,细菌可通过中耳炎或鼻窦炎等邻近感染的直接扩散、经先天性或获得…
细菌性脑膜炎始于脑膜炎奈瑟菌(Neisseria meningitidis)等病原体在鼻咽部定植并侵入血流,最终到达脑部血管。
它们通过血管内皮或脉络丛穿透血-脑屏障或血-脑脊液屏障,并到达蛛网膜下腔。
在此区域,免疫反应受到严格调控,使得细菌能够增殖并引发强烈的炎症反应,从而激活小胶质细胞和星形胶质细胞。
这些细胞分泌促炎性细胞因子,从而增加黏附分子的表达,并募集中性粒细胞进入脑脊液。
由此产生的炎症反应破坏血脑屏障,导致血管源性水肿和细胞毒性水肿,进而升高颅内压并降低脑灌注。
在某些情况下,血管炎症会触发内皮细胞活化及中性粒细胞介导的损伤,这可能促进微血栓形成,减少脑血流量并导致缺血性神经元损伤。
这种屏障破坏、水肿和血管损伤的级联反应导致细菌性脑膜炎的迅速进展。
View the full transcript and gain access to JoVE Core videos
Q1: How do bacteria reach the central nervous system in bacterial meningitis?
Bacteria such as Neisseria meningitidis colonize the nasopharynx and invade the bloodstream, eventually reaching cerebral vessels. They penetrate the blood-brain barrier or blood-cerebrospinal fluid barrier through the vascular endothelium or choroid plexus to reach the subarachnoid space. Bacterial virulence factors like polysaccharide capsules help resist immune defenses during this invasion.
Q2: What role do microglia and astrocytes play in bacterial meningitis pathophysiology?
Bacterial components like lipopolysaccharides and teichoic acids trigger activation of microglia and astrocytes in the subarachnoid space. These cells secrete proinflammatory cytokines including TNF-α, IL-1β, and IL-6, which increase adhesion molecule expression and recruit neutrophils into the cerebrospinal fluid, amplifying the inflammatory cascade.
Q3: How does inflammation disrupt the blood-brain barrier in meningitis?
Proinflammatory cytokines increase vascular permeability, causing vasogenic edema as plasma leaks into the extracellular space. Cytotoxic edema develops from inflammatory injury causing intracellular swelling of neurons and glia. Interstitial edema results from impaired cerebrospinal fluid reabsorption at arachnoid villi, collectively elevating increased intracranial pressure and impairing cerebral perfusion.
Q4: What is the relationship between vascular inflammation and neuronal damage in bacterial meningitis?
Vascular inflammation triggers endothelial activation and neutrophil-mediated injury, promoting microthrombi formation that reduces cerebral blood flow. This vascular injury causes ischemic neuronal damage by limiting oxygen delivery to brain tissue. The combination of barrier disruption, edema, and reduced perfusion creates a cascade leading to rapid disease progression.
Q5: Why is the subarachnoid space particularly vulnerable to bacterial proliferation?
The subarachnoid space has limited immune surveillance, allowing bacteria to multiply rapidly after crossing the blood-brain barrier. Cerebrospinal fluid lacks robust antimicrobial defenses compared to blood, enabling bacterial components to accumulate and trigger intense local inflammation. This environment facilitates the pathogenic cascade characteristic of bacterial meningitis.
Q6: What are the three types of edema that develop during bacterial meningitis?
Vasogenic edema occurs from increased vascular permeability allowing plasma leakage into extracellular space. Cytotoxic edema results from inflammatory injury causing intracellular swelling of neurons and glia. Interstitial edema develops from impaired cerebrospinal fluid reabsorption at arachnoid villi due to inflammatory exudates, potentially contributing to hydrocephalus.
Q7: How do bacterial virulence factors contribute to meningitis development?
Bacterial virulence factors such as polysaccharide capsules resist phagocytosis and complement-mediated killing, enabling pathogens to survive in the bloodstream and reach the central nervous system. Once in the subarachnoid space, bacterial components like lipopolysaccharides and teichoic acids trigger immune activation, initiating the inflammatory cascade that characterizes meningitis pathophysiology.